- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Angiotensin II Receptor Blockers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Angiotensin II Receptor Blockers market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Chronic Kidney Diseases accounting for % of the Angiotensin II Receptor Blockers global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Azilsartan segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Angiotensin II Receptor Blockers include Merck & Co., AstraZeneca, Novartis, Teva, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Angiotensin II Receptor Blockers market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Azilsartan
Candesartan
Eprosartan
Irbesartan
Losartan
Olmesartan
Telmisartan
Valsartan
Market segment by Application can be divided into
Chronic Kidney Diseases
Heart Failure
Kidney Failure in Diabetes
The key market players for global Angiotensin II Receptor Blockers market are listed below:
Merck & Co.
AstraZeneca
Novartis
Teva
Bayer
GlaxoSmithKline
Sun Pharmaceutical
Mylan
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Angiotensin II Receptor Blockers product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Angiotensin II Receptor Blockers, with price, sales, revenue and global market share of Angiotensin II Receptor Blockers from 2019 to 2022.
Chapter 3, the Angiotensin II Receptor Blockers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Angiotensin II Receptor Blockers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Angiotensin II Receptor Blockers market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Angiotensin II Receptor Blockers.
Chapter 13, 14, and 15, to describe Angiotensin II Receptor Blockers sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Angiotensin II Receptor Blockers Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Angiotensin II Receptor Blockers Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Azilsartan
1.2.3 Candesartan
1.2.4 Eprosartan
1.2.5 Irbesartan
1.2.6 Losartan
1.2.7 Olmesartan
1.2.8 Telmisartan
1.2.9 Valsartan
1.3 Market Analysis by Application
1.3.1 Overview: Global Angiotensin II Receptor Blockers Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chronic Kidney Diseases
1.3.3 Heart Failure
1.3.4 Kidney Failure in Diabetes
1.4 Global Angiotensin II Receptor Blockers Market Size & Forecast
1.4.1 Global Angiotensin II Receptor Blockers Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Angiotensin II Receptor Blockers Sales in Volume (2017-2028)
1.4.3 Global Angiotensin II Receptor Blockers Price (2017-2028)
1.5 Global Angiotensin II Receptor Blockers Production Capacity Analysis
1.5.1 Global Angiotensin II Receptor Blockers Total Production Capacity (2017-2028)
1.5.2 Global Angiotensin II Receptor Blockers Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Angiotensin II Receptor Blockers Market Drivers
1.6.2 Angiotensin II Receptor Blockers Market Restraints
1.6.3 Angiotensin II Receptor Blockers Trends Analysis
2 Manufacturers Profiles
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Angiotensin II Receptor Blockers Product and Services
2.1.4 Merck & Co. Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Angiotensin II Receptor Blockers Product and Services
2.2.4 AstraZeneca Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Angiotensin II Receptor Blockers Product and Services
2.3.4 Novartis Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva Angiotensin II Receptor Blockers Product and Services
2.4.4 Teva Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Angiotensin II Receptor Blockers Product and Services
2.5.4 Bayer Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Product and Services
2.6.4 GlaxoSmithKline Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sun Pharmaceutical
2.7.1 Sun Pharmaceutical Details
2.7.2 Sun Pharmaceutical Major Business
2.7.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Product and Services
2.7.4 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Angiotensin II Receptor Blockers Product and Services
2.8.4 Mylan Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Angiotensin II Receptor Blockers Breakdown Data by Manufacturer
3 Angiotensin II Receptor Blockers Breakdown Data by Manufacturer
3.1 Global Angiotensin II Receptor Blockers Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Angiotensin II Receptor Blockers Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Angiotensin II Receptor Blockers
3.4 Market Concentration Rate
3.4.1 Top 3 Angiotensin II Receptor Blockers Manufacturer Market Share in 2021
3.4.2 Top 6 Angiotensin II Receptor Blockers Manufacturer Market Share in 2021
3.5 Global Angiotensin II Receptor Blockers Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Angiotensin II Receptor Blockers Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4 Market Analysis by Region
4.1 Global Angiotensin II Receptor Blockers Market Size by Region
4.1.1 Global Angiotensin II Receptor Blockers Sales in Volume by Region (2017-2028)
4.1.2 Global Angiotensin II Receptor Blockers Revenue by Region (2017-2028)
4.2 North America Angiotensin II Receptor Blockers Revenue (2017-2028)
4.3 Europe Angiotensin II Receptor Blockers Revenue (2017-2028)
4.4 Asia-Pacific Angiotensin II Receptor Blockers Revenue (2017-2028)
4.5 South America Angiotensin II Receptor Blockers Revenue (2017-2028)
4.6 Middle East and Africa Angiotensin II Receptor Blockers Revenue (2017-2028)
5 Market Segment by Type
5 Market Segment by Type
5.1 Global Angiotensin II Receptor Blockers Sales in Volume by Type (2017-2028)
5.2 Global Angiotensin II Receptor Blockers Revenue by Type (2017-2028)
5.3 Global Angiotensin II Receptor Blockers Price by Type (2017-2028)
6 Market Segment by Application
6 Market Segment by Application
6.1 Global Angiotensin II Receptor Blockers Sales in Volume by Application (2017-2028)
6.2 Global Angiotensin II Receptor Blockers Revenue by Application (2017-2028)
6.3 Global Angiotensin II Receptor Blockers Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7 North America by Country, by Type, and by Application
7.1 North America Angiotensin II Receptor Blockers Sales by Type (2017-2028)
7.2 North America Angiotensin II Receptor Blockers Sales by Application (2017-2028)
7.3 North America Angiotensin II Receptor Blockers Market Size by Country
7.3.1 North America Angiotensin II Receptor Blockers Sales in Volume by Country (2017-2028)
7.3.2 North America Angiotensin II Receptor Blockers Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8 Europe by Country, by Type, and by Application
8.1 Europe Angiotensin II Receptor Blockers Sales by Type (2017-2028)
8.2 Europe Angiotensin II Receptor Blockers Sales by Application (2017-2028)
8.3 Europe Angiotensin II Receptor Blockers Market Size by Country
8.3.1 Europe Angiotensin II Receptor Blockers Sales in Volume by Country (2017-2028)
8.3.2 Europe Angiotensin II Receptor Blockers Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Angiotensin II Receptor Blockers Sales by Type (2017-2028)
9.2 Asia-Pacific Angiotensin II Receptor Blockers Sales by Application (2017-2028)
9.3 Asia-Pacific Angiotensin II Receptor Blockers Market Size by Region
9.3.1 Asia-Pacific Angiotensin II Receptor Blockers Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Angiotensin II Receptor Blockers Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10 South America by Region, by Type, and by Application
10.1 South America Angiotensin II Receptor Blockers Sales by Type (2017-2028)
10.2 South America Angiotensin II Receptor Blockers Sales by Application (2017-2028)
10.3 South America Angiotensin II Receptor Blockers Market Size by Country
10.3.1 South America Angiotensin II Receptor Blockers Sales in Volume by Country (2017-2028)
10.3.2 South America Angiotensin II Receptor Blockers Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Angiotensin II Receptor Blockers Sales by Type (2017-2028)
11.2 Middle East & Africa Angiotensin II Receptor Blockers Sales by Application (2017-2028)
11.3 Middle East & Africa Angiotensin II Receptor Blockers Market Size by Country
11.3.1 Middle East & Africa Angiotensin II Receptor Blockers Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Angiotensin II Receptor Blockers Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12 Raw Material and Industry Chain
12.1 Raw Material of Angiotensin II Receptor Blockers and Key Manufacturers
12.2 Manufacturing Costs Percentage of Angiotensin II Receptor Blockers
12.3 Angiotensin II Receptor Blockers Production Process
12.4 Angiotensin II Receptor Blockers Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Angiotensin II Receptor Blockers Typical Distributors
13.3 Angiotensin II Receptor Blockers Typical Customers
14 Research Findings and Conclusion
14 Research Findings and Conclusion
15 Appendix
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Angiotensin II Receptor Blockers Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Angiotensin II Receptor Blockers Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Angiotensin II Receptor Blockers Product and Services
Table 6. Merck & Co. Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Angiotensin II Receptor Blockers Product and Services
Table 10. AstraZeneca Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Angiotensin II Receptor Blockers Product and Services
Table 14. Novartis Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Teva Basic Information, Manufacturing Base and Competitors
Table 16. Teva Major Business
Table 17. Teva Angiotensin II Receptor Blockers Product and Services
Table 18. Teva Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Angiotensin II Receptor Blockers Product and Services
Table 22. Bayer Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Angiotensin II Receptor Blockers Product and Services
Table 26. GlaxoSmithKline Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Sun Pharmaceutical Major Business
Table 29. Sun Pharmaceutical Angiotensin II Receptor Blockers Product and Services
Table 30. Sun Pharmaceutical Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Angiotensin II Receptor Blockers Product and Services
Table 34. Mylan Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Angiotensin II Receptor Blockers Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Angiotensin II Receptor Blockers Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Angiotensin II Receptor Blockers, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Angiotensin II Receptor Blockers Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Angiotensin II Receptor Blockers Production Site of Key Manufacturer
Table 40. Angiotensin II Receptor Blockers New Entrant and Capacity Expansion Plans
Table 41. Angiotensin II Receptor Blockers Mergers & Acquisitions in the Past Five Years
Table 42. Global Angiotensin II Receptor Blockers Sales by Region (2017-2022) & (K Units)
Table 43. Global Angiotensin II Receptor Blockers Sales by Region (2023-2028) & (K Units)
Table 44. Global Angiotensin II Receptor Blockers Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Angiotensin II Receptor Blockers Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Angiotensin II Receptor Blockers Sales by Type (2017-2022) & (K Units)
Table 47. Global Angiotensin II Receptor Blockers Sales by Type (2023-2028) & (K Units)
Table 48. Global Angiotensin II Receptor Blockers Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Angiotensin II Receptor Blockers Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Angiotensin II Receptor Blockers Price by Type (2017-2022) & (USD/Unit)
Table 51. Global Angiotensin II Receptor Blockers Price by Type (2023-2028) & (USD/Unit)
Table 52. Global Angiotensin II Receptor Blockers Sales by Application (2017-2022) & (K Units)
Table 53. Global Angiotensin II Receptor Blockers Sales by Application (2023-2028) & (K Units)
Table 54. Global Angiotensin II Receptor Blockers Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Angiotensin II Receptor Blockers Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Angiotensin II Receptor Blockers Price by Application (2017-2022) & (USD/Unit)
Table 57. Global Angiotensin II Receptor Blockers Price by Application (2023-2028) & (USD/Unit)
Table 58. North America Angiotensin II Receptor Blockers Sales by Country (2017-2022) & (K Units)
Table 59. North America Angiotensin II Receptor Blockers Sales by Country (2023-2028) & (K Units)
Table 60. North America Angiotensin II Receptor Blockers Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Angiotensin II Receptor Blockers Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Angiotensin II Receptor Blockers Sales by Type (2017-2022) & (K Units)
Table 63. North America Angiotensin II Receptor Blockers Sales by Type (2023-2028) & (K Units)
Table 64. North America Angiotensin II Receptor Blockers Sales by Application (2017-2022) & (K Units)
Table 65. North America Angiotensin II Receptor Blockers Sales by Application (2023-2028) & (K Units)
Table 66. Europe Angiotensin II Receptor Blockers Sales by Country (2017-2022) & (K Units)
Table 67. Europe Angiotensin II Receptor Blockers Sales by Country (2023-2028) & (K Units)
Table 68. Europe Angiotensin II Receptor Blockers Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Angiotensin II Receptor Blockers Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Angiotensin II Receptor Blockers Sales by Type (2017-2022) & (K Units)
Table 71. Europe Angiotensin II Receptor Blockers Sales by Type (2023-2028) & (K Units)
Table 72. Europe Angiotensin II Receptor Blockers Sales by Application (2017-2022) & (K Units)
Table 73. Europe Angiotensin II Receptor Blockers Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Angiotensin II Receptor Blockers Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Angiotensin II Receptor Blockers Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Angiotensin II Receptor Blockers Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Angiotensin II Receptor Blockers Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Angiotensin II Receptor Blockers Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Angiotensin II Receptor Blockers Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Angiotensin II Receptor Blockers Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Angiotensin II Receptor Blockers Sales by Application (2023-2028) & (K Units)
Table 82. South America Angiotensin II Receptor Blockers Sales by Country (2017-2022) & (K Units)
Table 83. South America Angiotensin II Receptor Blockers Sales by Country (2023-2028) & (K Units)
Table 84. South America Angiotensin II Receptor Blockers Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Angiotensin II Receptor Blockers Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Angiotensin II Receptor Blockers Sales by Type (2017-2022) & (K Units)
Table 87. South America Angiotensin II Receptor Blockers Sales by Type (2023-2028) & (K Units)
Table 88. South America Angiotensin II Receptor Blockers Sales by Application (2017-2022) & (K Units)
Table 89. South America Angiotensin II Receptor Blockers Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Angiotensin II Receptor Blockers Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Angiotensin II Receptor Blockers Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Angiotensin II Receptor Blockers Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Angiotensin II Receptor Blockers Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Angiotensin II Receptor Blockers Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Angiotensin II Receptor Blockers Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Angiotensin II Receptor Blockers Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Angiotensin II Receptor Blockers Sales by Application (2023-2028) & (K Units)
Table 98. Angiotensin II Receptor Blockers Raw Material
Table 99. Key Manufacturers of Angiotensin II Receptor Blockers Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Angiotensin II Receptor Blockers Typical Distributors
Table 103. Angiotensin II Receptor Blockers Typical Customers
List of Figures
Figure 1. Angiotensin II Receptor Blockers Picture
Figure 2. Global Angiotensin II Receptor Blockers Revenue Market Share by Type in 2021
Figure 3. Azilsartan
Figure 4. Candesartan
Figure 5. Eprosartan
Figure 6. Irbesartan
Figure 7. Losartan
Figure 8. Olmesartan
Figure 9. Telmisartan
Figure 10. Valsartan
Figure 11. Global Angiotensin II Receptor Blockers Revenue Market Share by Application in 2021
Figure 12. Chronic Kidney Diseases
Figure 13. Heart Failure
Figure 14. Kidney Failure in Diabetes
Figure 15. Global Angiotensin II Receptor Blockers Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 16. Global Angiotensin II Receptor Blockers Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Angiotensin II Receptor Blockers Sales (2017-2028) & (K Units)
Figure 18. Global Angiotensin II Receptor Blockers Price (2017-2028) & (USD/Unit)
Figure 19. Global Angiotensin II Receptor Blockers Production Capacity (2017-2028) & (K Units)
Figure 20. Global Angiotensin II Receptor Blockers Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Angiotensin II Receptor Blockers Market Drivers
Figure 22. Angiotensin II Receptor Blockers Market Restraints
Figure 23. Angiotensin II Receptor Blockers Market Trends
Figure 24. Global Angiotensin II Receptor Blockers Sales Market Share by Manufacturer in 2021
Figure 25. Global Angiotensin II Receptor Blockers Revenue Market Share by Manufacturer in 2021
Figure 26. Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Angiotensin II Receptor Blockers Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Angiotensin II Receptor Blockers Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Angiotensin II Receptor Blockers Sales Market Share by Region (2017-2028)
Figure 30. Global Angiotensin II Receptor Blockers Revenue Market Share by Region (2017-2028)
Figure 31. North America Angiotensin II Receptor Blockers Revenue (2017-2028) & (USD Million)
Figure 32. Europe Angiotensin II Receptor Blockers Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Angiotensin II Receptor Blockers Revenue (2017-2028) & (USD Million)
Figure 34. South America Angiotensin II Receptor Blockers Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Angiotensin II Receptor Blockers Revenue (2017-2028) & (USD Million)
Figure 36. Global Angiotensin II Receptor Blockers Sales Market Share by Type (2017-2028)
Figure 37. Global Angiotensin II Receptor Blockers Revenue Market Share by Type (2017-2028)
Figure 38. Global Angiotensin II Receptor Blockers Price by Type (2017-2028) & (USD/Unit)
Figure 39. Global Angiotensin II Receptor Blockers Sales Market Share by Application (2017-2028)
Figure 40. Global Angiotensin II Receptor Blockers Revenue Market Share by Application (2017-2028)
Figure 41. Global Angiotensin II Receptor Blockers Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Angiotensin II Receptor Blockers Sales Market Share by Type (2017-2028)
Figure 43. North America Angiotensin II Receptor Blockers Sales Market Share by Application (2017-2028)
Figure 44. North America Angiotensin II Receptor Blockers Sales Market Share by Country (2017-2028)
Figure 45. North America Angiotensin II Receptor Blockers Revenue Market Share by Country (2017-2028)
Figure 46. United States Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Angiotensin II Receptor Blockers Sales Market Share by Type (2017-2028)
Figure 50. Europe Angiotensin II Receptor Blockers Sales Market Share by Application (2017-2028)
Figure 51. Europe Angiotensin II Receptor Blockers Sales Market Share by Country (2017-2028)
Figure 52. Europe Angiotensin II Receptor Blockers Revenue Market Share by Country (2017-2028)
Figure 53. Germany Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Angiotensin II Receptor Blockers Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Angiotensin II Receptor Blockers Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Angiotensin II Receptor Blockers Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Angiotensin II Receptor Blockers Revenue Market Share by Region (2017-2028)
Figure 62. China Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Angiotensin II Receptor Blockers Sales Market Share by Type (2017-2028)
Figure 69. South America Angiotensin II Receptor Blockers Sales Market Share by Application (2017-2028)
Figure 70. South America Angiotensin II Receptor Blockers Sales Market Share by Country (2017-2028)
Figure 71. South America Angiotensin II Receptor Blockers Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Angiotensin II Receptor Blockers Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Angiotensin II Receptor Blockers Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Angiotensin II Receptor Blockers Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Angiotensin II Receptor Blockers Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Angiotensin II Receptor Blockers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Angiotensin II Receptor Blockers in 2021
Figure 83. Manufacturing Process Analysis of Angiotensin II Receptor Blockers
Figure 84. Angiotensin II Receptor Blockers Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
